Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Kinevac

Generic name: Sincalide

FDA application holder: Bracco

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Kinevac?
Kinevac is a brand name of Sincalide, a prescription medicine. The FDA NDC Directory lists 1 Kinevac product in 1 strength and form.
Who makes Kinevac?
Bracco holds the FDA application for Kinevac (NDA017697, approved July 21, 1976).
Is there a generic or store brand of Kinevac?
Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Kinevac product. Ask your pharmacist whether one is right for you.
Has Kinevac been recalled?
FDA enforcement reports list 1 recall of Kinevac products; the newest started April 13, 2022. A recall usually concerns specific lots, not every product.

What Kinevac is

Each Kinevac product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Sincalide · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
sincalide 5 ug/5 mL
injection, powder, lyophilized, for solution (intravenous)
Kinevac 3 products, 3 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sincalide →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Kinevac products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA017697BraccoJuly 21, 19761

Companies that list Kinevac

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Kinevac products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. April 13, 2022 · Class II · Terminated · D-1087-2022

    cGMP deviations: Temperature abuse

    Kinevac (Sincalide for Injection), 5mcg per vial, 10 vials per box, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0556-15 — Mckesson Medical-Surgical Inc. Corporate Office

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers